These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2067002)

  • 1. New pepstatin analogues: synthesis and pepsin inhibition.
    McConnell RM; Frizzell D; Camp A; Evans A; Jones W; Cagle C
    J Med Chem; 1991 Jul; 34(7):2298-300. PubMed ID: 2067002
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effect of structure in subsite P3 on inhibition of pepsin.
    Rich DH; Bernatowicz MS
    J Med Chem; 1982 Jul; 25(7):791-5. PubMed ID: 6809942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of dideoxy-pepstatin. Mechanism of inhibition of porcine pepsin.
    Rich DH; Sun E; Singh J
    Biochem Biophys Res Commun; 1977 Jan; 74(2):762-7. PubMed ID: 319803
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effects of structure on inhibition of pepsin and renin.
    Rich DH; Sun ET; Ulm E
    J Med Chem; 1980 Jan; 23(1):27-33. PubMed ID: 6767029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of analogues of pepstatin. Effect of structure in subsites P1', P2', and P2 on inhibition of porcine pepsin.
    Rich DH; Salituro FG
    J Med Chem; 1983 Jun; 26(6):904-10. PubMed ID: 6406670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel semi-synthetic tight binding inhibitors of pepsin.
    Huddy SP; Patel G; Heywood GC; Austen BM; Hermon-Taylor J
    Biochem Soc Trans; 1989 Dec; 17(6):1124-5. PubMed ID: 2516823
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthetic and enzyme inhibition studies of pepstatin analogues containing hydroxyethylene and ketomethylene dipeptide isosteres.
    Holladay MW; Salituro FG; Rich DH
    J Med Chem; 1987 Feb; 30(2):374-83. PubMed ID: 3100803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition.
    Rich DH; Bernatowicz MS; Agarwal NS; Kawai M; Salituro FG; Schmidt PG
    Biochemistry; 1985 Jun; 24(13):3165-73. PubMed ID: 3927973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antipepsin activities of peptides having a valine or valylvaline moiety at the N-terminus.
    Okada K; Kurosawa Y; Nagai S
    Chem Pharm Bull (Tokyo); 1979 Sep; 27(9):2163-70. PubMed ID: 391419
    [No Abstract]   [Full Text] [Related]  

  • 10. Pepsin inhibition by a high specific activity radioiodinated derivative of pepstatin.
    Workman RJ; Burkitt DW
    Arch Biochem Biophys; 1979 Apr; 194(1):157-64. PubMed ID: 375833
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of inhibition of pepsin by pepstatin. Effect of inhibitor structure on dissociation constant and time-dependent inhibition.
    Rich DH; Sun ET
    Biochem Pharmacol; 1980 Aug; 29(16):2205-12. PubMed ID: 6775634
    [No Abstract]   [Full Text] [Related]  

  • 12. Solid-phase synthesis of a soluble pepstatin derivative suitable for therapeutic use.
    Austen BM; Ford TF; Grant DA; Hermon-Taylor J
    Biosci Rep; 1982 Jun; 2(6):427-32. PubMed ID: 6809068
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative pepstatin inhibition studies on individual human pepsins and pepsinogens 1,3 and 5(gastricsin) and pig pepsin A.
    Roberts NB; Taylor WH
    J Enzyme Inhib Med Chem; 2003 Jun; 18(3):209-17. PubMed ID: 14506911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ahpatinins, new acid protease inhibitors containing 4-amino-3-hydroxy-5-phenylpentanoic acid.
    Omura S; Imamura N; Kawakita K; Mori Y; Yamazaki Y; Masuma R; Takahashi Y; Tanaka H; Huang LY; Woodruff HB
    J Antibiot (Tokyo); 1986 Aug; 39(8):1079-85. PubMed ID: 3093433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pepstatin inhibition mechanism.
    Marciniszyn J; Hartsuck JA; Tang J
    Adv Exp Med Biol; 1977; 95():199-210. PubMed ID: 339690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of all the stereoisomers of statine (4-amino-3-hydroxy-6-methylheptanoic acid). Inhibition of pepsin activity by N-carbobenzoxy-L-valyl-L-valyl-statine derived from the four stereoisomers.
    Liu WS; Smith SC; Glover GI
    J Med Chem; 1979 May; 22(5):577-9. PubMed ID: 379333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a pepsin-inhibitory pentapeptide upon the peptic activity and acidity of gastric secretion.
    Svendsen LB; Guldager N; Christensen L; Christiansen PM
    Scand J Gastroenterol; 1976; 11(5):459-64. PubMed ID: 785587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of pepstatin-sensitive carboxyl proteases by using pepstatinyldansyldiaminopropane (dansyl-pepstatin) as an active site titrant.
    Yonezawa H; Uchikoba T; Kaneda M
    J Biochem; 1997 Aug; 122(2):294-9. PubMed ID: 9378705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auxiliary agents for the peroral administration of peptide and protein drugs: synthesis and evaluation of novel pepstatin analogues.
    Kratzel M; Hiessböck R; Bernkop-Schnürch A
    J Med Chem; 1998 Jun; 41(13):2339-44. PubMed ID: 9632367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Effect of a pepsin-inhibitory pentapeptide upon the gastric secretion of pepsin and hydrochloric acid.
    Christiansen PM; Svendsen LB; Guldager N; Christensen L
    Gut; 1975 Oct; 16(10):823-4. PubMed ID: 1107170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.